These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33405799)

  • 1. Oligotyrosines Inhibit Amyloid Formation of Human Islet Amyloid Polypeptide in a Tyrosine-Number-Dependent Manner.
    Xin Y; Zhang H; Hu Q; Tian S; Wang C; Luo L; Meng F
    ACS Biomater Sci Eng; 2019 Feb; 5(2):1092-1099. PubMed ID: 33405799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Toxic IAPP Amyloid by Extracts of Common Fruits.
    Kao PY; Green E; Pereira C; Ekimura S; Juarez D; Whyte T; Arhar T; Malaspina B; Nogaj LA; Moffet DA
    J Funct Foods; 2015 Jan; 12():450-457. PubMed ID: 26893614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformation-Dependent Manipulation of Human Islet Amyloid Polypeptide Fibrillation by Shiitake-Derived Lentinan.
    Xin Y; Wang X; Luo L; Meng F
    ACS Appl Mater Interfaces; 2018 Sep; 10(37):31069-31079. PubMed ID: 30148596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the roles of sulfated glycosaminoglycans in islet amyloid polypeptide amyloidogenesis and cytotoxicity.
    De Carufel CA; Nguyen PT; Sahnouni S; Bourgault S
    Biopolymers; 2013 Nov; 100(6):645-55. PubMed ID: 23526456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residue specific effects of human islet polypeptide amyloid on self-assembly and on cell toxicity.
    Khemtemourian L; Guillemain G; Foufelle F; Killian JA
    Biochimie; 2017 Nov; 142():22-30. PubMed ID: 28778718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulation on the inhibition mechanism of peptide-based inhibitor of islet amyloid polypeptide (IAPP) to islet amyloid polypeptide (IAPP
    Zhou S; Wang Q; Ren M; Zhang A; Liu H; Yao X
    Chem Biol Drug Des; 2017 Jul; 90(1):31-39. PubMed ID: 28004495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation.
    Caillon L; Lequin O; Khemtémourian L
    Biochim Biophys Acta; 2013 Sep; 1828(9):2091-8. PubMed ID: 23707907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin.
    Sellin D; Yan LM; Kapurniotu A; Winter R
    Biophys Chem; 2010 Aug; 150(1-3):73-9. PubMed ID: 20153100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: a synchrotron X-ray reflectivity study.
    Evers F; Jeworrek C; Tiemeyer S; Weise K; Sellin D; Paulus M; Struth B; Tolan M; Winter R
    J Am Chem Soc; 2009 Jul; 131(27):9516-21. PubMed ID: 19583433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide.
    Kapurniotu A; Bernhagen J; Greenfield N; Al-Abed Y; Teichberg S; Frank RW; Voelter W; Bucala R
    Eur J Biochem; 1998 Jan; 251(1-2):208-16. PubMed ID: 9492286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells.
    Oskarsson ME; Hermansson E; Wang Y; Welsh N; Presto J; Johansson J; Westermark GT
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2752-E2761. PubMed ID: 29507232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.
    Jeong HR; An SS
    Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane interaction of islet amyloid polypeptide.
    Jayasinghe SA; Langen R
    Biochim Biophys Acta; 2007 Aug; 1768(8):2002-9. PubMed ID: 17349968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro.
    Kayed R; Bernhagen J; Greenfield N; Sweimeh K; Brunner H; Voelter W; Kapurniotu A
    J Mol Biol; 1999 Apr; 287(4):781-96. PubMed ID: 10191146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.
    Jaikaran ET; Clark A
    Biochim Biophys Acta; 2001 Nov; 1537(3):179-203. PubMed ID: 11731221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myricetin Inhibits Islet Amyloid Polypeptide (IAPP) Aggregation and Rescues Living Mammalian Cells from IAPP Toxicity.
    Zelus C; Fox A; Calciano A; Faridian BS; Nogaj LA; Moffet DA
    Open Biochem J; 2012; 6():66-70. PubMed ID: 22792130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.
    Janson J; Ashley RH; Harrison D; McIntyre S; Butler PC
    Diabetes; 1999 Mar; 48(3):491-8. PubMed ID: 10078548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloidogenicity and cytotoxicity of islet amyloid polypeptide.
    Kapurniotu A
    Biopolymers; 2001; 60(6):438-59. PubMed ID: 12209476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Site-Specific Asparagine Deamidation in Islet Amyloid Polypeptide Amyloidogenesis: Key Contributions of Residues 14 and 21.
    Nguyen PT; Zottig X; Sebastiao M; Bourgault S
    Biochemistry; 2017 Jul; 56(29):3808-3817. PubMed ID: 28665109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the inhibition of truncated islet amyloid polypeptide aggregation by Cu(II): insights into the bioinorganic chemistry of type II diabetes.
    Rivillas-Acevedo L; Sánchez-López C; Amero C; Quintanar L
    Inorg Chem; 2015 Apr; 54(8):3788-96. PubMed ID: 25826050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.